---
title: "BioNTech Board Authorizes $1 Bln ADS Repurchase Program"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285534489.md"
description: "BioNTech SE (BNTX) has authorized a $1 billion program to repurchase American Depositary Shares (ADS) to meet business obligations and align with its capital allocation strategy. The repurchase program is valid until May 6, 2027. Currently, BNTX is trading at $95.34, reflecting a 0.09% increase in pre-market hours."
datetime: "2026-05-07T11:00:45.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285534489.md)
  - [en](https://longbridge.com/en/news/285534489.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285534489.md)
---

# BioNTech Board Authorizes $1 Bln ADS Repurchase Program

Add  as your preferred news source on Google

 Add Now

Thursday, BioNTech SE (BNTX) announced that its board has authorized a new program to repurchase American Depositary Shares or ADS for an aggregate amount of up to $1.0 billion.

The company intends to use the repurchased ADSs to satisfy obligations in the ordinary course of business. Also, it believes that the program is consistent with the company's capital allocation strategy as well as its commitment to sustainable value creation for the shareholders.

Repurchases under the program may be made until and including May 6, 2027.

In the pre-market hours, BNTX is trading at $95.34, up 0.09 percent on the Nasdaq.

For comments and feedback contact: editorial@rttnews.com

Business News

### Related Stocks

- [BNTX.US](https://longbridge.com/en/quote/BNTX.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [NDAQ.US](https://longbridge.com/en/quote/NDAQ.US.md)

## Related News & Research

- [AbbVie Inc. $ABBV Shares Purchased by RiverFront Investment Group LLC](https://longbridge.com/en/news/286750290.md)
- [Duality Biotherapeutics Exercises U.S. Cost and Profit-Sharing Option for BioNTech ADC](https://longbridge.com/en/news/286169551.md)
- [Enanta Pharma's RSV Bet And Immunology Ambitions](https://longbridge.com/en/news/286895623.md)
- [BUZZ-Street View: Regeneron's melanoma trial setback raises bigger-picture questions](https://longbridge.com/en/news/286769076.md)
- [14:05 ETLupin Receives Tentative Approval from U.S. FDA for Revefenacin Inhalation Solution](https://longbridge.com/en/news/286805922.md)